← Back to Search

Behavioral Intervention

Relapse Prevention for Alcoholism (ARCH-RPA Trial)

N/A
Recruiting
Led By Heidi Hutton, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed diagnosis of HIV
Aged 18 years or older
Must not have
Non-English speaking because interventions are currently available in English only
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new computerized intervention for people with alcohol use disorders. The intervention is designed to help prevent relapse.

Who is the study for?
This trial is for adults over 18 with HIV who are patients at Johns Hopkins HIV Clinic. They must have a history of alcohol use disorder, varying drinking patterns, and currently be abstinent or drinking minimally. Non-English speakers, those acutely suicidal or unable to consent are excluded.
What is being tested?
The study tests an adapted relapse prevention intervention for alcohol use disorders in people with HIV. It's a pilot trial comparing three groups: one gets computerized sessions, another person-delivered sessions, and the third group might receive usual care.
What are the potential side effects?
Since this is a behavioral intervention focusing on relapse prevention rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort discussing their alcohol use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with HIV.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in time to relapse
Secondary study objectives
Alcohol use pattern as assessed by change in number of days abstinent
Alcohol use pattern as assessed by change in number of drinking days
Alcohol use pattern as assessed by change in number of drinks per drinking day
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Person delivered RPIExperimental Treatment1 Intervention
2 session counselor delivered counseling to prevent relapse to hazardous drinking
Group II: Computer delivered RPIExperimental Treatment1 Intervention
2 session computer delivered counseling to prevent relapse to hazardous drinking
Group III: Treatment as UsualActive Control1 Intervention
Counseling for alcohol use available in clinic as treatment as usual

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,339 Previous Clinical Trials
14,881,616 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
839 Previous Clinical Trials
1,083,498 Total Patients Enrolled
Heidi Hutton, PhDPrincipal InvestigatorJohns Hopkins School of Medicine
Mary McCaul, PHDPrincipal InvestigatorJohns Hopkins University

Media Library

Relapse Prevention Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05163301 — N/A
HIV/AIDS Research Study Groups: Computer delivered RPI, Person delivered RPI, Treatment as Usual
Relapse Prevention Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05163301 — N/A
HIV/AIDS Clinical Trial 2023: Relapse Prevention Intervention Highlights & Side Effects. Trial Name: NCT05163301 — N/A
~57 spots leftby Feb 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top